Understanding Sickle cell disease: Causes, symptoms, and treatment options

被引:40
作者
Elendu, Chukwuka [1 ]
Amaechi, Dependable C. [2 ]
Alakwe-Ojimba, Chisom E. [3 ]
Elendu, Tochi C. [4 ]
Elendu, Rhoda C. [5 ]
Ayabazu, Chiagozie P. [6 ]
Aina, Titilayo O. [6 ]
Aborisade, Ooreofe [7 ]
Adenikinju, Joseph S. [8 ]
机构
[1] Fed Univ Teaching Hosp, Owerri, Nigeria
[2] Igbined Univ Okada, Okada, Nigeria
[3] Chukwuemeka Odumegwu Ojukwu Univ, Anambra State, Nigeria
[4] Imo State Univ, Owerri, Nigeria
[5] Van Horbachevsky Ternopil Natl Med Univ, Ternopol, Ukraine
[6] Babcock Univ, Ogun State, Nigeria
[7] Olabisi Onabanjo Univ Teaching Hosp, Shagamu, Nigeria
[8] Northwick Pk Hosp London Northwest NHS Trust, London, England
关键词
acute chest syndrome; disease-modifying therapies; hematopoietic stem cell transplantation; Sickle cell disease; stroke; vaso-occlusive crisis; ACUTE CHEST SYNDROME; ANEMIA; HEMOGLOBIN; TRANSPLANTATION; EPIDEMIOLOGY; PATHOGENESIS; TRANSFUSIONS; HYDROXYUREA; HEMOLYSIS; CHILDREN;
D O I
10.1097/MD.0000000000035237
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sickle cell disease (SCD) is a hereditary blood disorder characterized by the production of abnormal hemoglobin molecules that cause red blood cells to take on a crescent or sickle shape. This condition affects millions of people worldwide, particularly those of African, Mediterranean, Middle Eastern, and South Asian descent. This paper aims to provide an overview of SCD by exploring its causes, symptoms, and available treatment options. The primary cause of SCD is a mutation in the gene responsible for producing hemoglobin, the protein that carries oxygen in red blood cells. This mutation has abnormal hemoglobin called hemoglobin S, which causes red blood cells to become stiff and sticky, leading to various health complications. Patients with SCD may experience recurrent pain, fatigue, anemia, and increased infection susceptibility. Treatment options for SCD focus on managing symptoms and preventing complications. This includes pain management with analgesics, hydration, and blood transfusions to improve oxygen delivery. Hydroxyurea, a medication that increases the production of fetal hemoglobin, is commonly used to reduce the frequency and severity of pain crises. Additionally, bone marrow or stem cell transplants can cure select individuals with severe SCD. Finally, understanding the causes, symptoms, and treatment options for SCD is crucial for healthcare professionals, patients, and their families. It enables early diagnosis, effective symptom management, and improved quality of life for individuals with this chronic condition.
引用
收藏
页数:7
相关论文
共 43 条
[1]   Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life [J].
Adamkiewicz, Thomas V. ;
Silk, Benjamin J. ;
Howgate, James ;
Baughman, Wendy ;
Strayhorn, Gregory ;
Sullivan, Kevin ;
Farley, Monica M. .
PEDIATRICS, 2008, 121 (03) :562-569
[2]  
Adams RJ, 2005, NEW ENGL J MED, V353, P2769
[3]   Prevention of a first stroke by transfusions in children with sickle, cell anemia and abnormal results on transcranial Doppler ultrasonography [J].
Adams, RJ ;
McKie, VC ;
Hsu, L ;
Files, B ;
Vichinsky, E ;
Pegelow, C ;
Abboud, M ;
Gallagher, D ;
Kutlar, A ;
Nichols, FT ;
Bonds, DR ;
Brambilla, D ;
Woods, G ;
Olivieri, N ;
Driscoll, C ;
Miller, S ;
Wang, W ;
Hurlett, A ;
Scher, C ;
Berman, B ;
Carl, E ;
Jones, AM ;
Roach, ES ;
Wright, E ;
Zimmerman, RA ;
Waclawiw, M ;
Pearson, H ;
Powars, D ;
Younkin, D ;
El-Gammal, T ;
Seibert, J ;
Moye, L ;
Espeland, M ;
Murray, R ;
McKinley, R ;
McKinley, S ;
Hagner, S ;
Weiner, S ;
Estow, S ;
Yelle, M ;
Brock, K ;
Carter, E ;
Chiarucci, K ;
Debarr, M ;
Feron, P ;
Harris, S ;
Hoey, L ;
Jacques, K ;
Kuisel, L ;
Lewis, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (01) :5-11
[4]   Evaluation of Hemoglobin Cutoff Levels to Define Anemia Among Healthy Individuals [J].
Addo, O. Yaw ;
Yu, Emma X. ;
Williams, Anne M. ;
Young, Melissa Fox ;
Sharma, Andrea J. ;
Mei, Zuguo ;
Kassebaum, Nicholas J. ;
Jefferds, Maria Elena D. ;
Suchdev, Parminder S. .
JAMA NETWORK OPEN, 2021, 4 (08)
[5]   Evaluation of high performance liquid chromatography (HPLC) pattern and prevalence of beta-thalassaemia trait among sickle cell disease patients in Lagos, Nigeria [J].
Adeyemo, Titilope ;
Ojewunmi, Oyesola ;
Oyetunji, Ajoke .
PAN AFRICAN MEDICAL JOURNAL, 2014, 18
[6]  
[Anonymous], 2014, Evidence-based management of sickle cell disease: Expert panel report, 2014
[7]  
Ashley-Koch A, 2000, AM J EPIDEMIOL, V151, P839
[8]   Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease [J].
Aslan, M ;
Ryan, TM ;
Adler, B ;
Townes, TM ;
Parks, DA ;
Thompson, JA ;
Tousson, A ;
Gladwin, MT ;
Patel, RP ;
Tarpey, MM ;
Batinic-Haberle, I ;
White, CR ;
Freeman, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (26) :15215-15220
[9]   Sickle cell anaemia - Progress in pathogenesis and treatment [J].
Ballas, SK .
DRUGS, 2002, 62 (08) :1143-1172
[10]   Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice [J].
Belcher, JD ;
Mahaseth, H ;
Welch, TE ;
Otterbein, LE ;
Hebbel, RP ;
Vercellotti, GM .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (03) :808-816